PCV20 Pneumonia Vaccine
Why choose the 20-Strain PCV20 Pneumonia Vaccine
The 20-strain PCV20 (Pneumococcal Conjugate Vaccine 20-valent) is the latest innovation for preventing pneumococcal bacterial infection (Streptococcus pneumoniae). Developed as an advancement from the 13 and 15-valent vaccines, it provides broader coverage, enhanced protection against severe-disease-causing strains, and those that are commonly antibiotic-resistant. It is considered a worthwhile investment for health, offering the most comprehensive protection currently available for adults.
Summary of PCV20 Vaccine Benefits
Covers 20 strains: Protects against up to 20 pneumococcal serotypes.
Covers drug-resistant strains: Reduces the risk of complex and long-term treatment.
Single dose: For most adults and the elderly, no booster is required.
Reduces mortality rates: Protects vital organs, including lungs, bloodstream, and brain.
What is the PCV20 vaccine?
The PCV20 vaccine (Pneumococcal Conjugate Vaccine 20-valent) is an advanced pneumonia vaccine designed to protect against pneumococcal bacteria. It offers comprehensive coverage against 20 major strains, which are the leading causes of:
Pneumonia
Meningitis
Severe bloodstream infections (Sepsis)
Middle ear infections
Effectiveness of this pneumococcal vaccine
Reduces the risk of severe bloodstream infections by up to 75%.
Significantly lowers the risk of severe pneumonia and hospitalisation.
Helps prevent potentially life-threatening complications.
Who Should Get Vaccinated?
Young Children
The vaccine can be administered starting from 2 months of age.
Adults
Adults aged 50 and older.
Individuals aged 19–49 with a higher risk of pneumococcal infection due to underlying chronic conditions, such as diabetes, heart disease, chronic lung disease, or kidney disease.
Immunocompromised individuals.
Smokers.
Individuals with asthma or those at an increased risk of respiratory tract infections.
Why Should You Get the 20-Strain PCV20 Vaccine?
Severe pneumonia requiring prolonged hospitalisation.
Bloodstream infections (sepsis), which can be life-threatening.
Meningitis, potentially resulting in severe neurological complications.
For older adults, especially those with chronic conditions, recovery can be prolonged, and the risk of mortality is significantly higher. If infected, the symptoms are often much more severe than in the general population. Proactive prevention with a reliable pneumonia vaccine is the safer choice.
Essential Facts You Need to Know
The cost of treating pneumonia can easily exceed tens of thousands of baht, yet prevention takes less than 30 minutes. The PCV20 vaccine provides comprehensive coverage against 20 bacterial strains.
Significantly reduces the likelihood of severe illness and hospitalisation.
Lowers the risk of mortality among high-risk groups.
A convenient, single-dose pneumonia vaccine for older adults.
Establishes robust, long-term immunity.
Getting vaccinated is a safe and highly effective method of protection. Choosing the PCV20 vaccine is a proactive approach to “prevention before illness.” This advanced pneumococcal vaccine is especially crucial for young children, older adults, and individuals with underlying chronic conditions—because once an infection takes hold, the consequences can be far more severe than anticipated.
|
Limited-Time Offer (THB)
|
|---|
|
4,590
|
PCV20 Vaccine Package
Don’t Let Delay Turn Into Regret.
Book your vaccination today.
- Available from March 1 – June 30, 2026 only
- Contact BNH Hospital for consultation and appointment.
FAQ
Q: How does the PCV20 vaccine differ from older vaccines?
A: The key advantage of the PCV20 vaccine is the inclusion of 7 additional pneumococcal strains (compared to the older 13-valent vaccine). These added strains are frequently responsible for causing severe pneumonia, bloodstream infections, and meningitis in adults and the elderly.
Q: How long does immunity last after receiving the PCV20 pneumonia vaccine?
A: For individuals aged 50 and over, or adults with a healthy immune system, a single dose of this 20-strain pneumococcal vaccine is sufficient to stimulate long-lasting immunity. In most cases, a booster dose is not required, providing you with convenient “single-dose” protection.
Q: I have previously received the 13-valent or 15-valent pneumonia vaccine. Can I still get the PCV20 vaccine?
A: Yes, you can receive it to broaden your protection to cover all 20 strains. We highly recommend consulting a doctor to determine the appropriate timing for this vaccination (generally, an interval of at least 1 year from your previous vaccine is advised).
